# Omidria

NDC: 62225-600
Generic name: phenylephrine and ketorolac
Labeler / Manufacturer: Omeros Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAOCULAR
Marketing started: 20140613

FDA application: NDA205388

## Active ingredients

- KETOROLAC: 2.88 mg/mL
- PHENYLEPHRINE: 10.16 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62225-600"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62225-600
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21470688-4e81-4ea5-ac38-f72e10552e7e